The expected approval follows an advisory panel on Thursday recommending the Food and Drug Administration issue an emergency use authorization
- Moderna's will be the second Covid-19 vaccine cleared by the agency
- Pfizer / BioNTech was granted an EUA last week
Moderna’s vaccine can be more easily transported and stored than the Pfizer candidate. It may also be efficacious after the first dose.